Outcomes in Patients with Therapy-Related Acute Myeloid Leukemia (t-AML) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis
Publication
, Conference
Rizzieri, DA; Schiller, GJ; Solomon, SR; Newell, LF; Erba, HP; Ryan, RJ; Faderl, S; Cortes, JE; Lancet, JE
Published in: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
March 1, 2020
Duke Scholars
Published In
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
EISSN
1523-6536
ISSN
1083-8791
Publication Date
March 1, 2020
Volume
26
Issue
3
Start / End Page
S105 / S106
Location
Orlando, FL
Publisher
ELSEVIER SCIENCE INC
Conference Name
Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rizzieri, D. A., Schiller, G. J., Solomon, S. R., Newell, L. F., Erba, H. P., Ryan, R. J., … Lancet, J. E. (2020). Outcomes in Patients with Therapy-Related Acute Myeloid Leukemia (t-AML) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis. In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (Vol. 26, pp. S105–S106). Orlando, FL: ELSEVIER SCIENCE INC.
Rizzieri, David A., Gary J. Schiller, Scott R. Solomon, Laura F. Newell, Harry P. Erba, Robert J. Ryan, Stefan Faderl, Jorge E. Cortes, and Jeffrey E. Lancet. “Outcomes in Patients with Therapy-Related Acute Myeloid Leukemia (t-AML) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis.” In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26:S105–6. ELSEVIER SCIENCE INC, 2020.
Rizzieri DA, Schiller GJ, Solomon SR, Newell LF, Erba HP, Ryan RJ, et al. Outcomes in Patients with Therapy-Related Acute Myeloid Leukemia (t-AML) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC; 2020. p. S105–6.
Rizzieri, David A., et al. “Outcomes in Patients with Therapy-Related Acute Myeloid Leukemia (t-AML) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis.” BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 26, no. 3, ELSEVIER SCIENCE INC, 2020, pp. S105–06.
Rizzieri DA, Schiller GJ, Solomon SR, Newell LF, Erba HP, Ryan RJ, Faderl S, Cortes JE, Lancet JE. Outcomes in Patients with Therapy-Related Acute Myeloid Leukemia (t-AML) Who Achieved Remission with CPX-351 Versus 7+3: Phase 3 Exploratory Analysis. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC; 2020. p. S105–S106.
Published In
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
EISSN
1523-6536
ISSN
1083-8791
Publication Date
March 1, 2020
Volume
26
Issue
3
Start / End Page
S105 / S106
Location
Orlando, FL
Publisher
ELSEVIER SCIENCE INC
Conference Name
Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences